Odyssean LLC’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.29M Buy
207,640
+82,578
+66% +$1.93M 0.5% 65
2026
Q2
$3.22M Buy
+125,062
New +$2.57M 0.52% 29

Other funds holding DNLI

Odyssean LLC's DNLI Position: Q3 2026 in Review

Odyssean LLC increased its Denali Therapeutics (DNLI) stake by 66% in Q3 2026, buying an estimated $1.93M and bringing the position to 207,640 shares worth $4.29M. The position accounts for 0.5% of the portfolio, ranked #65.

Odyssean LLC first reported a position in DNLI in Q2 2026 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Odyssean LLC held 207,640 shares of Denali Therapeutics worth $4.29M as of Q3 2026.
  • Odyssean LLC bought 82,578 Denali Therapeutics shares in Q3 2026, an estimated $1.93M.
  • Denali Therapeutics made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #65 holding.
  • Odyssean LLC first reported a position in Denali Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.